Zurück
wo das Buy rating gesetzt wurde und das Kursziel von 1 auf 2 dollar hochgesetzt wurde
The platform’s potential has not gone unnoticed by Maxim’s Jason McCarthy. The analyst argues “the gp96 heatshock platform may be uniquely positioned to address COVID-19.” On top if its differentiated approach, McCarthy notes that perhaps most importantly, Heats' gp96 platform has been used in over 300 people so far and is “already demonstrating activity preclinically against a number of viruses.” These include numerous NIH (National Institutes of Health) and DOD (U.S. Department of Defense)-funded preclinical trials, against HIV/SIV, malaria, Zika and other infectious diseases.
“The results demonstrated potent immune response and induction of mucosal immunity in animal models. Importantly, these studies have also demonstrated immunity in a number of organs including the lungs,” McCarthy noted.
finance.yahoo.com/news/...cOPdX-CYy5gJoaWOreR_znQv3mMgs23U9JE
Der letzte Satz im ersten Abschnitt sagt ja schon aus das Heat Gelder für preclinical trials gegen verschiede Virenarten bekommt, warum also nicht auch für die Forschung gegen Corona.. da sich ja gp96 in verschiedenen Test aktivitäten gegen Viren gezeigt haben.. also schon was in der pipeline haben was nur noch verbessert etc werden muss..
Mal schauen wo die Reise hingeht..
The platform’s potential has not gone unnoticed by Maxim’s Jason McCarthy. The analyst argues “the gp96 heatshock platform may be uniquely positioned to address COVID-19.” On top if its differentiated approach, McCarthy notes that perhaps most importantly, Heats' gp96 platform has been used in over 300 people so far and is “already demonstrating activity preclinically against a number of viruses.” These include numerous NIH (National Institutes of Health) and DOD (U.S. Department of Defense)-funded preclinical trials, against HIV/SIV, malaria, Zika and other infectious diseases.
“The results demonstrated potent immune response and induction of mucosal immunity in animal models. Importantly, these studies have also demonstrated immunity in a number of organs including the lungs,” McCarthy noted.
finance.yahoo.com/news/...cOPdX-CYy5gJoaWOreR_znQv3mMgs23U9JE
Der letzte Satz im ersten Abschnitt sagt ja schon aus das Heat Gelder für preclinical trials gegen verschiede Virenarten bekommt, warum also nicht auch für die Forschung gegen Corona.. da sich ja gp96 in verschiedenen Test aktivitäten gegen Viren gezeigt haben.. also schon was in der pipeline haben was nur noch verbessert etc werden muss..
Mal schauen wo die Reise hingeht..
